KBLBKraig Biocraft Laboratories Inc
KBLB
Kraig Biocraft Laboratories Inc601
Mkt Cap
$167.34MVolume
670,297.0052W High
$0.1652W Low
$0.0716PE Ratio
-44.50KBLB Fundamentals
Price
$0.1513Prev Close
$0.1494Open
$0.15150D MA
$0.1312Beta
0.19Avg. Volume
1.61MEPS (Annual)
-$0.0034P/B
-12.39Rev/Employee
$0.00$95.76
This Market Is Moving Fast
The market is sending a clear signal: capital is flowing aggressively into platforms that can scale innovation, whether that’s next-generation immunotherapy, AI-driven digital ecosystems, or entirely new infrastructure for energy and materials. This week’s developments, from fresh biotech funding to explosive user growth in social platforms and bold pivots into clean energy, highlight a broader theme: investors are rewarding companies that are either accelerating commercialization or positioning themselves at critical bottlenecks in emerging industries. $CUE, $RDDT, $SOBR, $KBLB, $WTO, $AKAN
24-7 Market News·1d ago
Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations
Kraig Biocraft Laboratories (OTCQB: KBLB), a leading developer of recombinant spider silk-based fibers, has achieved two major commercialization milestones, signaling accelerating momentum toward the first successful spider silk commercialization program. The Company announced that a recent production run yielded approximately 1.8 metric tons of recombinant spider silk, marking a significant increase in output and establishing a new benchmark for commercial-scale production.
24-7 Market News·2d ago
Takeoffs and Turnarounds
The market narrative this week is being driven by a wave of aggressive execution, strategic pivots, and capital raises across emerging and turnaround stories. $KBLB, $BBBY, $SAFX, $NEXR, $BIYA, $ATER, $SNBR, $SKYQ, $AUUD, $SEGG, $NEXR, $CLYM
24-7 Market News·4d ago
Biotech Breakthroughs and Energy Deals Send These Stocks Soaring
A powerful wave of dealmaking, clinical breakthroughs, and infrastructure buildouts is driving renewed momentum with companies spanning energy, biotech, semiconductors, and AI ecosystems delivering headline-making developments. $USEG, $QUIK, $KBLB, $YAAS, $SGMT, $DKI, $GLND
24-7 Market News·5d ago
Chip Giants lead Breakout as Biotech Funding and Trading Frenzies re-emerge
The mega-cap semiconductors are breaking out on real earnings and AI demand, which is dominating the session, while liquidity is flowing into infrastructure and growth plays. $KBLB, $GOOG, $NVND, $INTC, $AMD, $POET, $CTNT, $SCNI
24-7 Market News·8d ago
TRT for Massive Gains
If you’re tired of getting sand kicked in your portfolio’s face, some of these stocks are hitting the gym and flexing. Not every stock here is ripped yet, but several are clearly bulking, a few are cutting into definition, and one or two might already be stepping on stage. $KBLB, $TZOO, $TRT, $AKAN, $TXN, $AUUD, $REPL
24-7 Market News·9d ago
$260M AI Mega-deal Ignites AGPU, while Other Stocks Surge toward Breakout Zone
Today’s tape is being driven by a powerful combination of AI infrastructure expansion, biotech breakthroughs, and momentum plays. OTCQB:KBLB, NASDAQ:POET, NASDAQ:AGPU, NASDAQ:ALP, NASDAQ:WBUY, NYSE:SRFM
24-7 Market News·10d ago
These Stocks Could Rip into the Close
As the market barrels into the final hour of trading, momentum is clustering around a powerful trio of themes, AI infrastructure, next-gen materials, and sustainable agriculture. $KBLB, $LOCL, $MRVL, $POET, $PALI, $FFAI
24-7 Market News·11d ago
From Supermarkets to Supercomputers
A fresh wave of momentum is sweeping through equities, where disruptive themes, from controlled-environment agriculture to AI-driven manufacturing and renewable-powered computing, are converging into a high-beta trading environment. $KBLB, $EDBL, $TGT, $LOCL, $LOBO, $FCHL, $SLNH
24-7 Market News·11d ago
Rogan’s Runners Market Ignites
The market is feeling the effect of Joe Rogan getting in President Trump’s ear and psychedelic therapeutics gaining regulatory tailwinds. Meanwhile, adjacent sectors are quietly building foundational breakthroughs. Wearables are evolving into neural interfaces, biomaterials are transitioning from lab curiosity to production reality, and oncology platforms continue their grind through clinical validation. $KBLB, $WLDS, $ARTL, $ENVB, $TOVX, $PBM, $CMND, $CMPS, $HELP,
24-7 Market News·12d ago
<
1
2
...
>